# Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.

> **NCT01291732** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Matching placebo
- **DRUG:** BI 135585 XX

## Key facts

- **NCT ID:** NCT01291732
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291732, "Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01291732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*